Anika Therapeutics reported $40.25M in Operating Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbott ABT:US $ 8983M 107M
Acorda Therapeutics ACOR:US $ 39.24M 9.29M
Agenus AGEN:US $ 61.4M 12.89M
Agios Pharmaceuticals AGIO:US $ 99.27M 2.91M
Anika Therapeutics ANIK:US $ 40.25M 4.7M
Arrowhead Research ARWR:US $ 110.25M 19.49M
Chemocentryx CCXI:US $ 43.69M 1.33M
Clovis Oncology CLVS:US $ 84.61M 6.4M
Enanta Pharmaceuticals ENTA:US $ 52.56M 5.49M
Halozyme Therapeutics HALO:US $ 41.61M 3.86M
Heron Therapeutics HRTX:US $ 86.38M 12.19M
Immunogen IMGN:US $ 60.93M 1.62M
Insmed INSM:US $ 142.94M 12.26M
Integra Lifesciences IART:US $ 329.18M 23.9M
Intrexon XON:US $ 49.92M 5.21M
Johnson & Johnson JNJ:US $ 17.56B 2.4B
Karyopharm Therapeutics KPTI:US $ 82.26M 2.95M
Ligand Pharmaceuticals LGND:US $ 53.5M 6.24M
Macrogenics MGNX:US $ 77.74M 5.36M
Merit Medical Systems MMSI:US $ 260.18M 3.59M
Peregrine Pharmaceuticals PPHM:US $ 28.24M 6.28M
Rigel Pharmaceuticals RIGL:US $ 43M 1.17M
Sangamo Biosciences SGMO:US $ 73.49M 5.61M
Stryker SYK:US $ 3.83B 58M
Surmodics SRDX:US $ 31.01M 4.56M
Veracyte VCYT:US $ 83.03M 3.36M
Xencor XNCR:US $ 59.03M 3.13M
Zimmer Biomet Holdings Inc ZBH:US $ 1.46B 659.1M